Published in J Neurol on January 18, 2008
Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A (2009) 1.83
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol (2009) 1.16
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease. Neuropathol Appl Neurobiol (2013) 0.98
Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models. Int J Mol Sci (2009) 0.82
Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes. Neurobiol Aging (2015) 0.81
Imaging small vessel-associated white matter changes in aging. Neuroscience (2013) 0.80
Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer's disease. Front Neurol (2012) 0.79
Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications. Neurohospitalist (2015) 0.78
Long-term neprilysin inhibition - implications for ARNIs. Nat Rev Cardiol (2016) 0.75
Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease. Sci Rep (2017) 0.75
[Amyloidoses in neuropathology]. Pathologe (2009) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke (1997) 4.07
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol (1995) 3.60
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain (2007) 2.93
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna) (2002) 2.55
Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology (2006) 2.38
Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke (1997) 2.38
High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00
Multiple simultaneous intracerebral hemorrhages: clinical features and outcome. Arch Neurol (2001) 1.83
Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke (1996) 1.60
Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke (2000) 1.44
Spatial distribution of hemorrhages in cerebral amyloid angiopathy. Ann Neurol (2006) 1.39
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31
Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke (1984) 1.30
Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord (2000) 1.30
Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci (1993) 1.27
Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord (2006) 1.26
Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol (2005) 1.26
Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol (1996) 1.26
Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol (1995) 1.22
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol (2001) 1.22
Amyloid angiopathy and lobar cerebral haemorrhage. J Neurol Neurosurg Psychiatry (1984) 1.16
Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci (2007) 1.16
Cerebrovascular amyloidosis with cerebral hemorrhage. J Neurol (1977) 1.14
Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Ann N Y Acad Sci (2000) 1.08
Cerebral microbleeds in Alzheimer's disease. J Neurol (2003) 1.07
Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol (2007) 1.05
Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension (1998) 1.04
Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy. J Neurol Sci (2007) 1.01
Cerebral amyloid angiopathy and dementia. Panminerva Med (2004) 0.99
Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology (2005) 0.98
Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype. Neuropathol Appl Neurobiol (2005) 0.95
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis (2006) 0.95
Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurol Scand (2006) 0.94
Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis (2005) 0.94
New neuropathological criteria for Alzheimer disease. Arch Neurol (1998) 0.93
Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage. J Zhejiang Univ Sci (2004) 0.93
Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol (1997) 0.92
Recurrence and extension of lobar hemorrhage related to cerebral amyloid angiopathy: multivariate analysis of clinical risk factors. Surg Neurol (2005) 0.90
High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1996) 0.90
Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors. Stroke (1999) 0.89
The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype. Acta Neuropathol (2006) 0.86
Lobar vs thalamic and basal ganglion hemorrhage: clinical and radiographic features. J Neurol (1987) 0.86
Sporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people. Age Ageing (2006) 0.84
APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid (2001) 0.79
Intracerebral hemorrhage caused by cerebral amyloid angiopathy: radiographic-pathologic correlation. AJNR Am J Neuroradiol (1984) 0.77
[Prevalence and characteristics of cerebral amyloid angiopathy in the elderly]. Zhonghua Nei Ke Za Zhi (2003) 0.75
Cerebral amyloid angiopathy as a cause of recurrent intracerebral hemorrhage. Conn Med (2002) 0.75
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain (2012) 2.17
Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol (2008) 1.72
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol (2013) 1.41
Spatial distribution of hemorrhages in cerebral amyloid angiopathy. Ann Neurol (2006) 1.39
The role of alpha-synuclein in the pathogenesis of multiple system atrophy. Acta Neuropathol (2005) 1.32
Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. Acta Neuropathol (2003) 1.29
Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol (2005) 1.26
Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci (2007) 1.16
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Elderly individuals with FTLD. JAMA Neurol (2013) 1.08
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol (2011) 1.06
Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol (2014) 1.05
Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J Alzheimers Dis (2005) 1.05
Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology (2006) 0.98
Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol (2006) 0.98
Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol (2004) 0.95
Chromogranin peptides in Alzheimer's disease. Exp Gerontol (2004) 0.92
Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Parkinsonism Relat Disord (2005) 0.91
Olfaction and Aging: A Mini-Review. Gerontology (2015) 0.91
Clinicopathological correlates of behavioral and psychological symptoms of dementia. Acta Neuropathol (2011) 0.90
The relationship between subcortical tau pathology and Alzheimer's disease. Biochem Soc Trans (2012) 0.88
Alzheimer's disease: a challenge for modern neuropathobiology. Acta Neuropathol (2009) 0.87
Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. J Alzheimers Dis (2005) 0.87
Critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol (2010) 0.85
Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia. Schizophr Res (2002) 0.84
The role of alpha-synuclein and tau in neurodegenerative movement disorders. Curr Opin Neurol (2005) 0.83
Age-associated prevalence and risk factors of Lewy body pathology in a general population. Acta Neuropathol (2003) 0.83
Amyloid and tau: neither chicken nor egg but two partners in crime! Acta Neuropathol (2013) 0.82
Pathogenesis and treatment of vascular cognitive impairment. Neurodegener Dis Manag (2014) 0.82
Chromogranin peptides in brain diseases. J Neural Transm (Vienna) (2011) 0.82
More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains. Acta Neuropathol (2007) 0.80
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2002) 0.80
Neuropathological subtypes of Alzheimer's disease. Acta Neuropathol (2011) 0.80
Prevalence of stroke in Parkinson's disease. Mov Disord (2003) 0.79
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol (2003) 0.79
Rhombencephalosynapsis. Acta Neuropathol (2002) 0.78
Neuropathology in Parkinson's disease with mild cognitive impairment. Acta Neuropathol (2010) 0.78
Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (2003) 0.77
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2004) 0.77
Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol (2005) 0.77
Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology (2008) 0.76
Prevalence of Alzheimer lesions in Parkinson's disease. Mov Disord (2003) 0.76
Neuropathology of dementia in Parkinson's disease. Ann Neurol (2006) 0.76
Intrathecal levels of IL-6 in Alzheimer's disease. J Neurol (2010) 0.76
Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol (2004) 0.76
Complex tauopathies versus tangle predominant dementia. Acta Neuropathol (2011) 0.76
Rapidly progressing diffuse Lewy body disease. Mov Disord (2011) 0.76
Diagnosis and differential diagnosis of MSA: boundary issues. J Neurol (2015) 0.75
P25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol (2006) 0.75
Neurochemical biomarkers in the differential diagnosis of movement disorders. Mov Disord (2010) 0.75
Dementia diagnosis. Am J Geriatr Psychiatry (2010) 0.75
Disturbance of the nigro-amygdaloid connections in dementia with Lewy bodies. J Neurol Sci (2002) 0.75
Potential role of α-synuclein in neurodegeneration: studies in a rat animal model. J Neurochem (2012) 0.75
Nigral pathology in older persons without Parkinson disease. Ann Neurol (2012) 0.75
Accuracy of diagnosis in dementia with Lewy bodies. Arch Neurol (2003) 0.75
Correspondence regarding: thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol 2010;69:449-54. J Neuropathol Exp Neurol (2010) 0.75
Striatal beta-amyloid deposition in Parkinson disease with dementia. J Neuropathol Exp Neurol (2008) 0.75
The neuropathologic substrate of Parkinson disease dementia. Acta Neuropathol (2009) 0.75
Clinico-pathological correlations in neurodegeneration. Acta Neuropathol (2011) 0.75
Commentary on "shining a light on posterior cortical atrophy". Alzheimers Dement (2013) 0.75
Parkinson disease with old-age onset. Arch Neurol (2003) 0.75
Elevated CNS concentrations of NFL in idiopathic normal pressure hydrocephalus (INPH) and subcortical arteriosclerotic encephalopathy (SAE). Acta Neurol Scand (2008) 0.75
Is Alzheimer's disease a vascular disorder? J Alzheimers Dis (2003) 0.75
Mortality in Parkinson's disease. Acta Neurol Scand (2005) 0.75
Neuropathologic changes in Parkinson disease with late onset of dementia. Arch Neurol (2003) 0.75
Young-onset multiple system atrophy. J Neurol Sci (2012) 0.75
Mild cognitive impairment: beyond memory dysfunction. Int J Alzheimers Dis (2012) 0.75
Alternatives to the suspended Alzheimer's disease vaccine. Acta Neuropathol (2002) 0.75
Change of Editor-in-Chief--but no farewell to scientific arms. Acta Neuropathol (2005) 0.75
Fifty years of Acta Neuropathologica: past, present, and future. Acta Neuropathol (2011) 0.75